This is great news, but can it get here fast enough:
The vaccine, manufactured by GlaxoSmithKline and developed by the National Institute of Allergy and Infectious Diseases in Maryland, has been fast-tracked in hopes that it can help turn the tide in the battle against the virus. Just a couple of weeks ago, it was tested on volunteers in the US and UK. Last month, it was successfully tested in monkeys with no ill effects. It’s not unusual for a typical vaccine to take as long as a year to go through the same process.
Via The Verge.1